For this purpose, blasts with high levels of Tim-3 expression were isolated from the bone marrow of AML patients and treated with IDA in the presence of anti-Tim-3 antibody or control IgG (Figure 3A). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.